Be the first to like this
By Quentin Soulet de Brugière, CTO at Dreem
Dreem is the kind of product we’ve all imagined to improve a key aspect of our lives: the quality of our sleep. After raising $35M last June, they are now hunting the mass market.
But it all started in a lab, becoming a reality via a major neuroscientific breakthrough.